Symfi is a prescription medication used to treat HIV-1 infection in adults and pediatric patients weighing at least 40 kg. It is a fixed-dose combination tablet containing three different antiretroviral drugs: efavirenz, lamivudine, and tenofovir disoproxil fumarate. These drugs work together to help control the HIV virus and prevent it from multiplying in the body.

Efavirenz is a non-nucleoside reverse transcriptase inhibitor, while lamivudine and tenofovir disoproxil fumarate are nucleoside reverse transcriptase inhibitors. By combining these drugs into one convenient tablet, Symfi simplifies the treatment regimen for patients with HIV-1 infection.

It is important to take Symfi exactly as prescribed by your healthcare provider. Missing doses or not taking the medication as directed can lead to the development of drug-resistant strains of HIV. It is also important to follow up regularly with your healthcare provider to monitor your response to treatment and any potential side effects.

Common side effects of Symfi may include dizziness, trouble sleeping, nausea, and rash. These side effects are usually mild and temporary, but it is important to notify your healthcare provider if you experience any severe or persistent side effects while taking Symfi.

Overall, Symfi is an effective and well-tolerated treatment option for individuals living with HIV-1 infection. By following your healthcare provider’s instructions and staying informed about your treatment, you can effectively manage your condition and live a healthy, fulfilling life.